104 related articles for article (PubMed ID: 38735616)
1. Future prospect of polysaccharide as a potential therapy in hepatocellular carcinoma: A review.
Cai Y; Guo J; Kang Y
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132300. PubMed ID: 38735616
[TBL] [Abstract][Full Text] [Related]
2. Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review.
Yu Y; Shen M; Song Q; Xie J
Carbohydr Polym; 2018 Mar; 183():91-101. PubMed ID: 29352896
[TBL] [Abstract][Full Text] [Related]
3. Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth.
Shu G; Zhao W; Yue L; Su H; Xiang M
J Ethnopharmacol; 2015 Jun; 168():237-47. PubMed ID: 25858511
[TBL] [Abstract][Full Text] [Related]
4. Basil polysaccharide attenuates hepatocellular carcinoma metastasis in rat by suppressing H3K9me2 histone methylation under hepatic artery ligation-induced hypoxia.
Feng B; Zhu Y; Su Z; Tang L; Sun C; Li C; Zheng G
Int J Biol Macromol; 2018 Feb; 107(Pt B):2171-2179. PubMed ID: 29042275
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo.
Xiang J; Xiang Y; Lin S; Xin D; Liu X; Weng L; Chen T; Zhang M
Tumour Biol; 2014 Apr; 35(4):3517-24. PubMed ID: 24310501
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of polysaccharides on hepatic injury: A review.
Yuan Y; Che L; Qi C; Meng Z
Int J Biol Macromol; 2019 Dec; 141():822-830. PubMed ID: 31487518
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome and liver cancer: mechanisms and clinical translation.
Yu LX; Schwabe RF
Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
[TBL] [Abstract][Full Text] [Related]
8. Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma.
Tang L; Chen R; Xu X
Cancer Lett; 2020 Apr; 476():120-128. PubMed ID: 32070778
[TBL] [Abstract][Full Text] [Related]
9. Antitumor immunostimulatory activity of the traditional Chinese medicine polysaccharide on hepatocellular carcinoma.
Liu Y; Wu J; Hao H
Front Immunol; 2024; 15():1369110. PubMed ID: 38455058
[TBL] [Abstract][Full Text] [Related]
10. Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma.
Bie B; Sun J; Guo Y; Li J; Jiang W; Yang J; Huang C; Li Z
Biomed Pharmacother; 2017 Sep; 93():1285-1291. PubMed ID: 28747003
[TBL] [Abstract][Full Text] [Related]
11. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma.
Kong FH; Ye QF; Miao XY; Liu X; Huang SQ; Xiong L; Wen Y; Zhang ZJ
Theranostics; 2021; 11(11):5464-5490. PubMed ID: 33859758
[TBL] [Abstract][Full Text] [Related]
12. Effect of fucoidan on the biotinidase kinetics in human hepatocellular carcinoma.
Hayakawa K; Nagamine T
Anticancer Res; 2009 Apr; 29(4):1211-7. PubMed ID: 19414366
[TBL] [Abstract][Full Text] [Related]
13. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
14. Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
Gnocchi D; Kapoor S; Nitti P; Cavalluzzi MM; Lentini G; Denora N; Sabbà C; Mazzocca A
J Mol Med (Berl); 2020 Feb; 98(2):179-191. PubMed ID: 31863151
[TBL] [Abstract][Full Text] [Related]
15. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma.
Turato C; Balasso A; Carloni V; Tiribelli C; Mastrotto F; Mazzocca A; Pontisso P
J Control Release; 2017 Dec; 268():184-197. PubMed ID: 29051062
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeted therapy for hepatocellular carcinoma: current and future.
Shin JW; Chung YH
World J Gastroenterol; 2013 Oct; 19(37):6144-55. PubMed ID: 24115810
[TBL] [Abstract][Full Text] [Related]
17. Effects of cartilage polysaccharide on apoptosis of human hepatoma BEL-7402 cells and murine H22 hepatocarcinoma.
Liu A; Han X; Zhang G; Zhao X; Zheng G
Int J Food Sci Nutr; 2009; 60 Suppl 6():47-58. PubMed ID: 19184762
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization, antioxidant and anti-proliferative activities of a polysaccharide extracted from psyllium (P. ovata) leaves.
Patel MK; Tanna B; Mishra A; Jha B
Int J Biol Macromol; 2018 Oct; 118(Pt A):976-987. PubMed ID: 29964112
[TBL] [Abstract][Full Text] [Related]
19. Ter-cell, A New Target for Hepatocellular Carcinoma Therapy.
Cen X; Cheng K
Chembiochem; 2018 Nov; 19(21):2254-2256. PubMed ID: 30136761
[TBL] [Abstract][Full Text] [Related]
20. Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
Swamy SG; Kameshwar VH; Shubha PB; Looi CY; Shanmugam MK; Arfuso F; Dharmarajan A; Sethi G; Shivananju NS; Bishayee A
Target Oncol; 2017 Feb; 12(1):1-10. PubMed ID: 27510230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
